SI-BONE Reports Q1 2026 Financial Results and Raises Guidance

SI-BONE, Inc., a leader in procedural solutions for compromised bone, reported its financial results for Q1 2026, highlighting a revenue increase of 11.2% to $52.6 million. U.S. revenue grew to $49.3 million, bolstered by product adoption and expanded sales coverage. The company also announced an improved operating loss and net loss figures. Looking ahead, SI-BONE raised its 2026 revenue guidance to $230-$233 million, projecting a 14-16% year-over-year growth.